KOD
KOD
NASDAQ · Biotechnology

Kodiak Sciences Inc

$33.70
-0.10 (-0.30%)
As of Sep 23, 1:36 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target -62.0% upside
Low Target $8.80
Average Target $12.80
High Target $18.52
Current Price $33.70
Current
$33.70
Target
$12.80
$8.80 $12.80 avg $18.52
Scenario Analysis
Bear Case
$8.80
-73.9%
Low target
Base Case
$12.80
-62.0%
Avg target
Bull Case
$18.52
+-45.0%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$47.84
-29.6% from high
52-Week Low
$9.10
+270.3% from low
Target vs 52W High
$12.80
-73.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.8%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -15.1%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -17.9%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.2%